1 Min Read
March 13 (Reuters) - Five Prime Therapeutics Inc:
* BELSKY WILL CONTINUE IN HIS CURRENT ROLE UNTIL APRIL 6, 2018 Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.